Aratana Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PETX and buy or sell other stocks, ETFs, and their options commission-free!About PETX
Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT.
CEOCraig A. Tooman, MBA
CEOCraig A. Tooman, MBA
Employees—
Employees—
HeadquartersLeawood, Kansas
HeadquartersLeawood, Kansas
Founded2010
Founded2010
Employees—
Employees—
PETX Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$7.16
52 Week high$7.16
52 Week low$3.30
52 Week low$3.30
Stock Snapshot
Aratana Therapeutics(PETX) stock is priced at $4.92.
Aratana Therapeutics(PETX) stock opened on 2025-11-07 at —. The price climbed to — and dipped to —.
The Aratana Therapeutics(PETX)'s current trading volume is 0.
During the past year, Aratana Therapeutics(PETX) stock moved between $3.30 at its lowest and $7.16 at its peak.
During the past year, Aratana Therapeutics(PETX) stock moved between $3.30 at its lowest and $7.16 at its peak.